Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007;30:734–43.CrossRefPubMed

Harrison SA. Liver disease in patients with diabetes mellitus. J Clin Gastroenterol. 2006;40:68–76.CrossRefPubMed

Byrd KK, Mehal JM, Schillie SF, Holman RC, Haberling D, Murphy T. Chronic liver disease-associated hospitalizations among adults with diabetes, national inpatient sample, 2001–2012. Public Health Rep. 2015;130:693–703.PubMedPubMedCentral

Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, arcia-Tsao G G, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of cirrhotic patients. Hepatology. 2016;64:200–8.CrossRefPubMed

Wild SH, Morling JR, McAllister DA, Kerssens J, Fischbacher C, Parkes J, et al. Type 2 diabetes and risk of hospital admission or death for chronic liver disease. J Hepatol. 2016;64:1358–64.CrossRefPubMed

Wong VW, Chalasani N. Not routine screening, but vigilance for chronic liver disease in patients with type 2 diabetes. J Hepatol. 2016;64:1211–3.CrossRefPubMed

Elkrief L, Chouinard P, Bendesky N, Hajage D, Larroque B, Babany G, et al. Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C. Hepatology. 2014;60:823–31.CrossRefPubMed

Jeon HK, Kim MY, Baik SK, Park HJ, Choi H, Park SY, et al. Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage. Dig Dis Sci. 2013;58:3335–41.CrossRefPubMed

Jepsen P, Watson H, PK A, Vilstrup H. Diabetes as a risk for hepatic encephalopathy in cirrhosis patients. J Hepatol. 2015;63:1133–8.CrossRefPubMed